The clinical course of acute haemolytic anaemia varies in duration and severity depending on many factors: first and foremost, drug dose, but also baseline haemoglobin level and other individual variables, including the G6PD variant itself. Here, G6PD is linked to non-autoimmune hemolytic anemia.